CASS4 Gene Helps Brain Immune Cells Isolate Toxic Alzheimer’s Plaques

A newly identified genetic mechanism may help treat Alzheimer’s disease by activating the brain’s internal waste-processing system, according to research published in the Journal of Experimental Medicine.

The discovery centers on the CASS4 gene, which enables immune cells to isolate toxic plaques that accumulate in the brain. While previous studies identified CASS4 as a risk factor, its specific biological role remained largely unknown until recent experiments conducted by UVA Health. Alzheimer’s is characterized by the buildup of tau-protein tangles and amyloid-beta plaques, which disrupt communication between neurons and lead to cognitive decline. Specialized immune cells known as microglia normally defend the brain by surrounding these plaques and compressing them into smaller, less harmful clusters. Research led by Dr. John Lukens using mouse models revealed that when CASS4 function is disrupted, microglia can no longer effectively contain these plaques.

This failure accelerates plaque growth, destroys neurons, and reduces mental capacity, contradicting earlier assumptions that the gene primarily operated within neurons rather than the immune system.

“The biological role of CASS4 had remained unknown despite its known link to the disease,” Addie Walsh, the study’s lead author, told Newsmonkey -. Dr. Lukens suggests the findings open two primary avenues for future medical intervention.

The research team is exploring the use of CASS4 malfunctions as a biomarker for early detection and the development of treatments designed to boost the gene’s activity to slow disease progression.

These results are currently limited to preclinical stages, and further research is required to confirm if immune-focused strategies are safe and effective for human patients. More than six million people in the United States currently suffer from Alzheimer’s disease.

Photo of author

Health Desk

Health Desk at Archyde.

Durands Join Tenant’s Objection to Son’s First Estate Account Settlement